Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Examining a patient for common or complex pulmonary issues in a primary care setting takes time and expertise — physicians need to ask about symptoms and medical history and determine which tests to ...

The American Lung Association wants to increase uptake of screening and biomarker testing to improve lung cancer outcomes. (LunaKate/Getty Images) Guardant Health is joining in on the American Lung ...

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is ...

Even as biomarker testing has become increasingly important for selecting the right lung cancer treatment, the time it takes to order these tests hasn't improved. Overall, the time from biopsy to ...

What if a simple blood test could tell you that lung cancer might develop years before it actually appears? It sounds like ...

Credit: Getty Images The road to race-neutral pulmonary function testing has been long and evolving; now, ATS recommends this approach and a Boston hospital offers an implementation model. In July, ...

It’s been a year since Australia launched its National Lung Cancer Screening Program. Since July 2025, about 100,000 ...

Biodesix, Inc. has announced that new research will be showcased at upcoming conferences, including the ISPOR 2025 Annual Meeting in Montreal and the ATS 2025 International Conference in San Francisco ...

Mucor PCR testing of bronchoalveolar lavage (BAL) fluid showed high specificity in identifying invasive pulmonary mucormycosis (IPM) in lung transplant recipients, especially when used in conjunction ...